Patent · US Active

Heterocyclic compound as CSF-1R inhibitor and use thereof

US11384065B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Wenyuan Qian · Newbury Park, US
Chundao Yang · Shanghai, CN
Guanghai Xu · Shanghai, CN
Jie Li · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jan 3, 2019
Grant date	Jul 12, 2022
Priority date	—
Expiry date	Jan 17, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a class of isoindolinone derivatives and use thereof in the preparation of a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. In particular, the present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof or a stereoisomer thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.